Allometric scaling of clearance in dogs

Journal of Veterinary Pharmacology and Therapeutics

Volumn 32, Issue 5, 2009, Pages 411-416

  Martinez, M ^a   Mahmood, I ^a   Hunter, R P ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b ELANCO ANIMAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CARUMONAM; ENROFLOXACIN; FUROSEMIDE; METHOHEXITAL; PHENAZONE; THIAMPHENICOL; THIOPENTAL;

ALLOMETRY; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; BREED DIFFERENCE; DATA ANALYSIS; DOG; DRUG CLEARANCE; DRUG EXPOSURE; DRUG METABOLISM; NONHUMAN; PRIORITY JOURNAL; VALIDITY;

ANIMALS; BODY WEIGHT; DOGS; HUMANS; METABOLIC CLEARANCE RATE; RABBITS; SPECIES SPECIFICITY; VETERINARY DRUGS;

CANIS FAMILIARIS;

EID: 70349131195     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2009.01062.x     Document Type: Article

References (25)

1. Bachmann, K. (1989) Predicting toxicokinetic parameters in humans from toxicokinetic data acquired from three small mammalian species. Journal of Applied Toxicology, 9, 331 338.
2. Balani, S.K., Zhu, T., Yang, T.J., Liu, Z., He, B. Lee, F.W. (2002) Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys. Drug Metabolism and Disposition, 30, 1059 1062.
3. Boxenbaum, H. (1982) Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. Journal of Pharmacokinetics and Biopharmaceutics, 10, 201 227.
4. Boxenbaum, H. Fertig, J.B. (1984) Scaling of antipyrine intrinsic clearance of unbound drug on 15 mammalian species. European Journal of Drug Metabolism and Pharmacokinetics, 9, 177 183.
5. Bregante, M.A., Saez, P., Aramayona, J.J., Fraile, L., Garcia, M.A. Solans, C. (1999) Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows. American Journal of Veterinary Research, 60, 1111 1116.
6. Caldwell, J., Gardner, I. Swales, N. (1995) An introduction to drug disposition: the basic principles of absorption, distribution, metabolism, and excretion. Toxicologic Pathology, 23, 102 114.
7. Castells, G., Capece, B.P., Perez, F., Marti, G., Arboix, M. Cristofol, C. (2001) Allometric analysis of thiamphenicol disposition among seven mammalian species. Journal of Veterinary Pharmacology and Therapeutics, 24, 193 197.
8. Doyle, E., Chasseaud, L.F. Miller, J.N. (1982) Comparative pharmacokinetics of frusemide in female rhesus monkeys, cynomolgus monkeys and baboons. Comparative Biochemistry and Physiology C., 71C, 89 93.
9. Fleischer, S., Sharkey, M., Mealey, K., Ostrander, E.A. Martinez, M. (2008) Pharmacogenetic and metabolic differences between dog breeds: their impact on canine medicine and the use of the dog as a preclinical animal model. AAPS Journal, 10, 110 119.
10. Galtier, M., Briand, D., Pinguet, F., Gomeni, R., Fabre, D. Bressolle, F. (1995) Pharmacokinetic parameters of antipyrine in dog after hepatectomy. Biopharmaceutics and Drug Disposition, 16, 669 684.
11. Gurley, B.J., Barone, G.W., Yamashita, K., Polston, S., Estes, M. Harden, A. (1997) Extrahepatic ischemia-reperfusion injury reduces hepatic oxidative drug metabolism as determined by serial antipyrine clearance. Pharmaceutical Research, 14, 67 72.
12. Hirai, J., Miyazaki, H. Taneike, T. (1992) The pharmacokinetics and pharmacodynamics of furosemide in the anaesthetized dog. Journal of Veterinary Pharmacology and Therapeutics, 15, 231 239.
13. Hunter, R.P. Isaza, R. (2008) Concepts and issues with interspecies scaling in zoological pharmacology. Journal of Zoo and Wildlife Medicine, 39, 517 526.
14. Kita, Y., Fugono, T. Imada, A. (1986) Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys. Antimicrobial Agents and Chemotherapy, 29, 127 134.
15. KuKanich, B. Coetzee, J.F. (2008) Comparative pharmacokinetics of amikacin in Greyhound and Beagle dogs. Journal of Veterinary Pharmacology and Therapeutics, 31, 102 107.
16. Kukanich, B., Coetzee, J.F., Gehring, R. Hubin, M. (2007) Comparative disposition of pharmacologic markers for cytochrome P-450 mediated metabolism, glomerular filtration rate, and extracellular and total body fluid volume of Greyhound and Beagle dogs. Journal of Veterinary Pharmacology and Therapeutics, 30, 314 319.
17. Kung, K., Riond, J.L. Wanner, M. (1993) Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. Journal of Veterinary Pharmacology and Therapeutics, 16, 462 468.
18. Lin, J.H. (1998) Applications and limitations of interspecies scaling and in-vitro extrapolation in pharmacokinetics. Drug Metabolism and Disposition, 26, 1202 1212.
19. Mahmood, I. (2005) Interspecies scaling of clearance. In Interspecies Pharmacokinetics Scaling: Principles and Application of Allometric Scaling. Ed. Mahmood, I., pp. 39 85. Pine House Publishers, Rockville, MD.
20. Mahmood, I. Balian, J.D. (1996) Interspecies scaling: predicting clearance of drugs in humans. Three different approaches. Xenobiotica, 26, 887 895.
21. Mordenti, J., Chen, S.A., Moore, J.A., Ferraiolo, B.L. Green, J.D. (1991) Interspecies scaling of CL and volume of distribution data for five therapeutic proteins. Pharmaceutical Research, 8, 1351 1359.
22. Paulson, S.K., Vaughn, M.B., Jessen, S.M., Lawal, Y., Gresk, C.J., Yan, B., Maziasz, T.J., Cook, C.S. Karim, A. (2001) Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption. Journal of Pharmacology and Experimental Therapeutics, 297, 638 645.
23. Ramanathan-Girish, S., McColm, J., Clements, J.M., Taupin, P., Barrowcliffe, S., Hevizi, J., Safrin, S., Moore, C., Patou, G., Moser, H., Gadd, A., Hoch, U., Jiang, V., Lofland, D. Johnson, K.W. (2004) Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor. Antimicrobial Agents and Chemotherapy, 48, 4835 4842.
24. Sams, R.A., Muir, W.W., Detra, R.L. Robinson, E.P. (1985) Comparative pharmacokinetics and anesthetic effects of methohexital, pentobarbital, thiamylal, and thiopental in Greyhound dogs and non-Greyhound, mixed-breed dogs. American Journal of Veterinary Research, 46, 1677 1683.
25. Tang, C., Shou, M., Rushmore, T.H., Mei, Q., Sandhu, P., Woolf, E.J., Rose, M.J., Gelmann, A., Greenberg, H.E., De Lepeleire, I., Van Hecken, A., De Schepper, P.J., Ebel, D.L., Schwartz, J.I. Rodrigues, A.D. (2001) In-vitro metabolism of celecoxib, a cyclooxygenase-2 inhibitor, by allelic variant forms of human liver microsomal cytochrome P450 2C9: correlation with CYP2C9 genotype and in-vivo pharmacokinetics. Pharmacogenetics, 11, 223 235.